Showing results (791-800 of 826) with videos related to

Sort By:
Pageof 83
Memorias Do Instituto Oswaldo Cruz|June 4, 2025
Use of Brazilian flora as the main source of new antimalarials: a systematic reviewAna Rafaela Antunes Porto, Isabela de Brito Duval, Luisa Vitor Braga do Amaral, et al.
Hematological Oncology|October 17, 2022
Circulating cell-free DNA for target quantification in hematologic malignancies: Validation of a protocol to overcome pre-analytical biasesRoberta Soscia, Irene Della Starza, Lucia Anna De Novi, et al.
International Journal of Molecular Sciences|June 12, 2026
Comparative Analysis Between the EuroClonality-NGS Approach and the LymphoTrack<sup>®</sup> Dx Assay for IG/TR Marker Screening in Lymphoid Leukemias: A Campus ALL StudyIrene Della Starza, Vittorio Bellomarino, Mariangela Di Trani, et al.
Genes, Chromosomes & Cancer|May 13, 2011
13q14 deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemiaMichele Dal Bo, Francesca Maria Rossi, Davide Rossi, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 5, 2013
Sucrose ingestion induces rapid AMPA receptor traffickingDavid S Tukey, Jainne M Ferreira, Shannon O Antoine, et al.
Giornale Italiano Di Cardiologia (2006)|May 27, 2026
[SICOA-GISE Consensus document on carotid atherosclerotic disease: from increased intima-media thickness to stenosis. Diagnostic and therapeutic management]Mario De Michele, Francesco Saia, Giovanni Esposito, et al.
Leukemia Research|December 9, 2015
Dasatinib first-line: Multicentric Italian experience outside clinical trialsMassimo Breccia, Fabio Stagno, Luigiana Luciano, et al.
Neoplasia (New York, N.Y.)|September 24, 2016
Frontline Dasatinib Treatment in a "Real-Life" Cohort of Patients Older than 65 Years with Chronic Myeloid LeukemiaRoberto Latagliata, Fabio Stagno, Mario Annunziata, et al.
Pageof 83